DRUG ERRORS GO UNDER THE MICROSCOPE

Published Online: Thursday, March 1, 2007

Purdue University is investigating medication errors and providing recommendations for preventing them. Backed by a $25-million grant from Lilly Endowment Inc, the newly formed special team of researchers will establish a program that will reduce medication errors and enable pharmacists, physicians, and nurses to hone their skills by improving drug distribution and administration systems.

The university plans to develop community-based models to better use pharmacists to help with early detection and management of adverse drug events. As a model, the medication-error response team will use Purdue's Technical Assistance Program, which connects Indiana companies with Purdue resources, to create a pharmaceutical technical assistance program. The researchers also will develop systems, much like those currently found in industry, to reduce drug errors.




Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues
$auto_registration$
VSEO N/A